Takeda Pharmaceutical (TAK) Total Debt Growth (3y) (2021 - 2026)
Takeda Pharmaceutical (TAK) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 92.83% |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | 72.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.67% |
| Mar 31, 2026 | 68.32% |
| Dec 31, 2025 | 0.18% |
| Sep 30, 2025 | -0.90% |
| Jun 30, 2025 | -4.74% |
| Mar 31, 2025 | -7.50% |
| Dec 31, 2024 | -5.51% |
| Sep 30, 2024 | -6.36% |
| Jun 30, 2024 | -6.56% |
| Mar 31, 2024 | -0.53% |
| Dec 31, 2023 | -11.68% |
| Sep 30, 2023 | -10.51% |
| Jun 30, 2023 | -8.23% |
| Mar 31, 2023 | -9.98% |
| Sep 30, 2022 | 71.78% |
| Jun 30, 2022 | 76.02% |
| Mar 31, 2022 | -10.55% |
| Dec 31, 2021 | 21.70% |
| Mar 31, 2021 | -8.25% |